About this episode

Sylvie Stacy, MD, MPH, discusses the potential of GLP-1s in treating substance use disorders.

Sylvie Stacy, MD, MPH, joins Over the Counter to discuss the emerging evidence regarding GLP-1s for various types of substance use disorders and the potential role this medication class can play for millions of vulnerable patients.

More episodes of Over the Counter

• The Pharmacy Rewards Program Improving Outcomes Through Key Partnerships · May 7, 2026 · 20 min
• Pharmacy Accreditation Requires Ongoing Diligence for Network Access · April 23, 2026 · 13 min
• What Pharmacies Need to Know About FDA Shift to 12-Digit NDCs · April 16, 2026 · 15 min
• What the Walgreens ‘Hybrid Pharmacist’ Role is Doing for Workforces Challenges · April 9, 2026 · 12 min
• Unpacking the FDA’s Sweeping Proposal to Move All Drugs to OTC · March 26, 2026 · 20 min
• Diabetes Alert Day: The Pharmacist’s Powerful Role in Diabetes Care · March 24, 2026 · 22 min

Explore listener stats, chart rankings, contacts and more on the Over the Counter podcast page.